🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study purpose is to evaluate the effect of QAB149 * NVA237 vs. QAB149 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11
Trial ID
NCT01699685
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
The purpose of the study is to provide long term safety data of NVA237. Thi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10
Trial ID
NCT01697696
Treatments Being Tested
This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2010-03
Trial ID
NCT01089127
Treatments Being Tested
The study was designed to obtain data about the efficacy and safety of 3 do...
Status
Completed
Location
Novartis Investigative site
Start Date
2006-12
Trial ID
NCT00403845
Treatments Being Tested
This study is being conducted to assess the effect of indacaterol (150 μg o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-11
Trial ID
NCT01012765
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of indacaterol...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01712516
This study in COPD patients will investigate the bronchodilatory effect of ...
Status
Completed
Location
Research Site
Start Date
2012-03
Trial ID
NCT01498081
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled, three-period ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-05
Trial ID
NCT03257995
Treatments Being Tested
This study assessed the efficacy, safety, tolerability, and pharmacokinetic...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-10
Trial ID
NCT01012739